Hanlim Pharm Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-03-14
- Employees
- 251
- Market Cap
- -
- Website
- http://hanlim.com
Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee
Phase 3
Completed
- Conditions
- Knee Osteoarthritis
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-01-15
- Last Posted Date
- 2019-07-02
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 338
- Registration Number
- NCT01768520
- Locations
- 🇰🇷
The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon, Kyoung-gi Do, Korea, Republic of
Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
- First Posted Date
- 2013-01-15
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 84
- Registration Number
- NCT01768312
- Locations
- 🇰🇷
The catholic university of Korea seoul st. Mary's hospital, Seoul, Seocho-Ku, Korea, Republic of
Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin
Phase 1
Completed
- Conditions
- Healthy Male Volunteers
- Interventions
- First Posted Date
- 2013-01-14
- Last Posted Date
- 2018-08-03
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01767610
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, Korea, Republic of
Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis
Phase 4
Completed
- Conditions
- Osteoporosis
- Interventions
- Drug: Risedronate/Cholecalciferol combination
- First Posted Date
- 2012-08-29
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 1053
- Registration Number
- NCT01675297
- Locations
- 🇰🇷
Chung-ang university hospital, Seoul, Korea, Republic of
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Healthy Male Subjects
- Interventions
- Drug: Lodivixx tab. 5/160mg
- First Posted Date
- 2012-07-30
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT01652339
- Locations
- 🇰🇷
Inje University Busan Paik Hospital, Busan, Korea, Republic of
The Pharmacokinetic Interaction Between Celecoxib and Rebamipide
Phase 1
Completed
- Conditions
- Healthy Male Volunteers
- Interventions
- First Posted Date
- 2012-03-09
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT01549743
- Locations
- 🇰🇷
The Korea Univertisy Anam Hospital, Seoul, Korea, Republic of
Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis
Phase 3
Completed
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- First Posted Date
- 2011-11-11
- Last Posted Date
- 2013-08-27
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 347
- Registration Number
- NCT01470053
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath